Medical Equipment Companies By Ps Ratio

Price To Sales
Price To SalesEfficiencyMarket RiskExp Return
1GUTS Fractyl Health, Common
604.93
(0.13)
 5.04 
(0.64)
2DXR Daxor
309.12
(0.08)
 2.27 
(0.19)
3INO Inovio Pharmaceuticals
289.67
(0.04)
 4.42 
(0.19)
4MGRM Monogram Orthopaedics Common
243.53
 0.04 
 8.32 
 0.35 
5ADGM Adagio Medical Holdings,
205.44
 0.15 
 14.99 
 2.25 
6HSCS Heart Test Laboratories
202.07
 0.00 
 4.29 
 0.01 
7NXL Nexalin Technology
130.89
(0.13)
 6.22 
(0.80)
8COCH Envoy Medical
125.12
 0.00 
 3.70 
(0.01)
9AVR Anteris Technologies Global
101.59
(0.14)
 6.71 
(0.94)
10PTHL Pheton Holdings Ltd
97.29
 0.00 
 9.52 
(0.03)
11CATX Perspective Therapeutics
94.22
(0.16)
 4.87 
(0.78)
12BSGM BioSig Technologies, Common
90.04
(0.08)
 9.00 
(0.71)
13LQDA Liquidia Technologies
83.37
 0.05 
 3.07 
 0.14 
14ICU LMF Acquisition Opportunities
82.66
(0.04)
 6.72 
(0.27)
15PLSE Pulse Biosciences
60.23
 0.02 
 4.50 
 0.11 
16BJDX Bluejay Diagnostics
54.99
 0.03 
 17.46 
 0.48 
17CLGN Collplant Biotechnologies
53.83
(0.26)
 2.99 
(0.76)
18NYXH Nyxoah
51.26
(0.19)
 4.40 
(0.83)
19SPAI Safe Pro Group
48.5
 0.00 
 12.19 
 0.00 
20OBIO Orchestra BioMed Holdings
40.96
(0.13)
 6.16 
(0.77)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries. The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.